Review article · 30 May 2024
Conference abstractPublished 28 Sep 2015
Understanding tumoral markers in patients with pancreatic cancer
1University of Medicine and Pharmacy âÂ?Â?Gr.T.PopaâÂ? Iasi, Romania 2Alexandru Ioan CuzaâÂ? University, Iasi, Romania
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The pancreatic cancer is a disease with exponentially increased incidence, especially over the last decades, being the sixth or even fifth cause of death by cancer in most of the modern societies. Moreover, it is estimated that the majority of the patients with this disease are presenting to the doctor in the advanced and unresectable stages. Thus, the only way of establishing a diagnosis in the early stage, potentially curable, would be a rigorous anamnesis that would reveal the early symptoms to âÂ?Â?sendâÂ?Â? the patient to the doctor in the early stage. In this way, all hopes are turning to early diagnosis and/or the discovery of an effective therapeutic agent. Thus, in the present report we will be interested in presenting the relevance for the serum determination of some tumoral markers, such as CA19-9 (carbohydrate antigen 19-9) and CEA (carcinoembryonic antigen) in our selected patients with pancreatic cancer. In this way, our results are showing the relevance in determining these specific tumoral markers, especially as predictors for recurrences after pancreatic neoplasm surgery, since the determination of the serum level of CA 19-9 seem to be relevant in the cases when the antigen level drops immediately after the surgery, then increases progressively, highlighting the emergence of recurrence.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 31 Aug 2023
Implications of Cell Surface Markers, Prognosis, Resistance, Metastasis, and Treatment Methods for Pancreatic Cancer Stem Cells
Research article · 2018
Expression of Classical Embryonic Stem Cell Markers in Pancreatic Cancer Cells
Conference abstract · 28 Sep 2015
The relevance of some molecular markers in recurrent pancreatic cancer: Focusing on CA 19-9 and cytokeratins
Research article · 30 Jun 2023
Investigating the impact of key tumor markers to predict and reduction of lymphoma cancer diagnosis duration with a data mining approach
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Alin Ciobica”
- BylineArticles whose byline prints “Daniel Timofte”
- BylineArticles whose byline prints “Radu Danila”
- BylineArticles whose byline prints “Corneliu Diaconu”
- BylineArticles whose byline prints “Roxana Livadaru”
- BylineArticles whose byline prints “Emil Anton”
- BylineArticles whose byline prints “Lidia Ionescu”

